Latest news
Injection molded ICOcap
The development of Iconovo's proprietary capsule based inhaler, ICOcap has reached an important milestone. The first mold tools have been manufactured…
Pulmonary Drug Delivery: Advances and Challenges
Orest Lastow is the co-author of a recently published book titled "Pulmonary Drug Delivery: Advances and Challenges". The book addresses problems associated…
Press releases
Oct 25, 2019, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
Oct 25, 2019, 08:15
News
IR
English
Corporate Information
Other Corporate Information
Oct 25, 2019, 08:15
News
IR
Swedish
Corporate Information
Other Corporate Information
Aug 16, 2019, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q2
Jul 10, 2019, 14:23
News
IR
Swedish
Corporate Information
Other Corporate Information
May 15, 2019, 19:26
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
May 03, 2019, 16:26
News
IR
Swedish
Corporate Information
Other Corporate Information
Apr 25, 2019, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
Apr 18, 2019, 09:20
News
IR
Swedish
Corporate Information
Other Corporate Information
Apr 15, 2019, 09:21
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Mar 29, 2019, 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Mar 19, 2019, 21:17
News
IR
Swedish
Corporate Information
Other Corporate Information
Mar 19, 2019, 21:09
News
IR
Swedish
Corporate Information
Other Corporate Information
Feb 14, 2019, 08:45
News
IR
Swedish
Regulatory
MAR
Report
Interim
Yearend
Feb 04, 2019, 10:58
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
Jan 25, 2019, 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Dec 17, 2018, 09:16
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
Nov 30, 2018, 09:15
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Nov 09, 2018, 08:45
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
Nov 08, 2018, 15:45
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
CEO
Anders Månsson
Mail: anders.mansson@iconovo.se
Press releases
Follow us on Linkedin
